Site icon Grmbulls

Emcure Pharma IPO: Everything You Need to Know

Emcure Pharmaceuticals Limited, a prominent name in the Indian pharmaceutical industry, is set to launch its IPO, aiming to raise ₹1,952.03 crores. This comprehensive guide provides all the critical details, key dates, and financial insights about the Emcure Pharma IPO.

Key Details of Emcure Pharma IPO

The Emcure Pharma IPO consists of a fresh issue and an offer for sale. Here is a detailed overview:

IPO ComponentDetails
Total Issue Size₹1,952.03 crores
Fresh Issue0.79 crore shares aggregating to ₹800.00 crores
Offer for Sale1.14 crore shares aggregating to ₹1,152.03 crores

This table highlights the breakdown of the total issue size, indicating both the fresh issue and the offer for sale components.

Important Dates for Emcure Pharma IPO

The timeline for the Emcure Pharma IPO is crucial for investors. Below are the key dates to remember:

EventDate
IPO Opening DateJuly 3, 2024
IPO Closing DateJuly 5, 2024
Basis of Allotment FinalizationJuly 8, 2024
Initiation of RefundsJuly 9, 2024
Credit of Shares to DematJuly 9, 2024
Listing DateJuly 10, 2024

This table summarizes the tentative schedule for the IPO, ensuring investors are aware of all important deadlines.

Price Band and Lot Size Of Emcure Pharma IPO

The Emcure Pharma IPO has set a price band and lot size that investors need to consider:

Price Band₹960 to ₹1008 per share
Minimum Lot Size14 Shares
Minimum Investment (Retail)₹14,112
Minimum Investment (sNII)₹211,680 (15 lots, 210 shares)
Minimum Investment (bNII)₹1,001,952 (71 lots, 994 shares)

This table provides the price band and investment requirements for different investor categories.

Emcure Pharma IPO Reservation Details

The IPO has specific reservation categories, ensuring fair distribution among different types of investors:

Investor CategoryShares Offered
QIBNot more than 50% of the Net Issue
RetailNot less than 35% of the Net Issue
NII (HNI)Not more than 15% of the Net Issue

This table explains the reservation details, giving clarity on the allocation for various investor categories.

Financial Performance and Key Metrics Of Emcure Pharma IPO

The financial data of Emcure Pharmaceuticals Limited showcases the company’s performance over the years:

Financial Metrics31 Mar 202431 Mar 202331 Mar 2022
Assets₹7,806.16 Cr₹6,672.53 Cr₹6,063.47 Cr
Revenue₹6,715.24 Cr₹6,031.72 Cr₹5,918.86 Cr
Profit After Tax₹527.58 Cr₹561.85 Cr₹702.56 Cr
Net Worth₹2,952.28 Cr₹2,501.13 Cr₹1,987.55 Cr
Reserves & Surplus₹2,722.40 Cr₹2,293.77 Cr₹1,791.03 Cr
Total Borrowing₹2,091.94 Cr₹2,202.42 Cr₹2,102.19 Cr

This table presents the financial performance, showcasing key metrics such as assets, revenue, profit, and more.

Key Performance Indicators Of Emcure Pharma IPO

Emcure Pharma’s key performance indicators (KPIs) provide insight into the company’s efficiency and profitability:

KPIValue
Market Capitalization₹19,029.89 Cr
ROE16.90%
ROCE19.37%
Debt/Equity0.67
RoNW16.87%
P/BV6.18

This table highlights critical KPIs, reflecting the company’s market standing and financial health.

Objectives of the Emcure Pharma IPO

The funds raised through the IPO will be utilized for:

  1. Repayment and/or prepayment of certain outstanding borrowings.
  2. General corporate purposes.

Promoter Holding and Company Overview Of Emcure Pharma IPO

Emcure Pharmaceuticals Limited, incorporated in 1981, is a leading Indian pharmaceutical company. Here’s an overview of promoter holdings and company details:

PromoterHolding Pre IssueHolding Post Issue
Satish Mehta98.90%
Sunil Mehta98.90%

This table provides information about the company promoters and their shareholding percentages.

Contact and Registrar Details Of Emcure Pharma IPO

For any inquiries or issues, investors can contact Emcure Pharmaceuticals Limited or their IPO registrar:

Emcure Pharmaceuticals LimitedRegistrar
Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Pune – 411 057Link Intime India Private Ltd
Phone: +91 20 3507 0033Phone: +91-22-4918 6270
Email: investors@emcure.co.inEmail: emcure.ipo@linkintime.co.in
Website: Emcure PharmaceuticalsWebsite: Link Intime

This table provides the contact details of Emcure Pharmaceuticals and their IPO registrar for investor assistance.

Conclusion

Emcure Pharmaceuticals Limited’s IPO is a significant opportunity for investors, offering a well-established company with a robust financial background. With a clear understanding of the IPO details, investment requirements, and financial performance, investors can make informed decisions.

For those looking to delve deeper into the specifics, the Emcure Pharma IPO RHP provides comprehensive information. To create a demat account and start investing, visit GRM Bulls for seamless financial services and trading learning.

Stay updated and make informed investment decisions with GRM Bulls!

Exit mobile version